![Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus | Nature Biotechnology Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus | Nature Biotechnology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnbt.2020/MediaObjects/41587_2011_Article_BFnbt2020_Fig2_HTML.jpg)
Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus | Nature Biotechnology
![Viruses | Free Full-Text | Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets Viruses | Free Full-Text | Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets](https://www.mdpi.com/viruses/viruses-11-00030/article_deploy/html/images/viruses-11-00030-g001.png)
Viruses | Free Full-Text | Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets
![Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus | Science Translational Medicine Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus | Science Translational Medicine](https://www.science.org/cms/asset/cfcaff6b-b180-43d0-9fea-58ef501c92ba/2-30ra32-f1.gif)
Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus | Science Translational Medicine
![Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus | Nature Biotechnology Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus | Nature Biotechnology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnbt.2020/MediaObjects/41587_2011_Article_BFnbt2020_Fig3_HTML.jpg)
Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus | Nature Biotechnology
Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle | Journal of Medicinal Chemistry
![Molecules | Free Full-Text | Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary Molecules | Free Full-Text | Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary](https://www.mdpi.com/molecules/molecules-27-00850/article_deploy/html/images/molecules-27-00850-g002.png)
Molecules | Free Full-Text | Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary
![Development and Marketing of INCIVEK (Telaprevir; VX-950): A First-Generation HCV Protease Inhibitor, in Combination with PEGylated Interferon and Ribavirin | SpringerLink Development and Marketing of INCIVEK (Telaprevir; VX-950): A First-Generation HCV Protease Inhibitor, in Combination with PEGylated Interferon and Ribavirin | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F7355_2018_57/MediaObjects/458489_1_En_57_Fig15_HTML.png)
Development and Marketing of INCIVEK (Telaprevir; VX-950): A First-Generation HCV Protease Inhibitor, in Combination with PEGylated Interferon and Ribavirin | SpringerLink
![Validating Enterovirus D68-2Apro as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2Apro Inhibitor | Journal of Virology Validating Enterovirus D68-2Apro as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2Apro Inhibitor | Journal of Virology](https://journals.asm.org/cms/10.1128/jvi.02221-18/asset/1244e4cb-1e97-46d7-8916-5cd9a3ae0701/assets/graphic/jvi.02221-18-f0001.jpeg)
Validating Enterovirus D68-2Apro as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2Apro Inhibitor | Journal of Virology
![Investigation of some benzoquinazoline and quinazoline derivatives as novel inhibitors of HCV-NS3/4A protease: biological, molecular docking and QSAR ... - RSC Advances (RSC Publishing) DOI:10.1039/D0RA05604A Investigation of some benzoquinazoline and quinazoline derivatives as novel inhibitors of HCV-NS3/4A protease: biological, molecular docking and QSAR ... - RSC Advances (RSC Publishing) DOI:10.1039/D0RA05604A](https://pubs.rsc.org/image/article/2020/RA/d0ra05604a/d0ra05604a-f3_hi-res.gif)